• Company
• Two new CML drugs were granted reimbursement in one year
• by Eo, Yun-Ho Apr 8, 2024 05:46am

• Company
• Early breast cancer treatments fail to get reimb in KOR
• by Eo, Yun-Ho Apr 8, 2024 05:46am

• Company
• Sanofi’s Dupixent sales skyrocket after expanded indication
• by Nho, Byung Chul Apr 8, 2024 05:46am

• Policy
• 'Need patient engagement for reimb of high-priced drugs'
• by Lee, Tak-Sun Apr 8, 2024 05:46am

• Policy
• Recalls of antiplatelet drugs containing 'clopidogrel'…
• by Lee, Hye-Kyung Apr 5, 2024 05:44am

• Company
• High dose Eylea approved in KOR… extends dosing interval
• by Son, Hyung-Min Apr 5, 2024 05:43am

• Company
• AbbVie Korea, 52% increase in sales last year…
• by Kim, Jin-Gu Apr 5, 2024 05:43am

• Policy
• Orphan drug Ilaris receives conditional pass for reimb again
• by Lee, Hye-Kyung Apr 5, 2024 05:43am

• Policy
• HIRA in final stages of preparing expense report survey
• by Lee, Tak-Sun Apr 5, 2024 05:43am

• Policy
• Trajenta generics enter reimbursement pricing…
• by Lee, Tak-Sun Apr 5, 2024 05:43am